Cargando…
A robust design for identification of the Parasite Clearance Estimator
BACKGROUND: Anti-malarial efficacy needs to be monitored continually to ensure optimal dosing in the face of emerging anti-malarial drug resistance. The efficacy of artemisinin based combination therapies (ACT) is assessed by repeated measurements of parasite density in the blood of patients followi...
Autores principales: | Jamsen, Kris M, Duffull, Stephen B, Tarning, Joel, Price, Ric N, Simpson, Julie A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831256/ https://www.ncbi.nlm.nih.gov/pubmed/24225256 http://dx.doi.org/10.1186/1475-2875-12-410 |
Ejemplares similares
-
Towards optimal design of anti-malarial pharmacokinetic studies
por: Simpson, Julie A, et al.
Publicado: (2009) -
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
por: Jamsen, Kris M, et al.
Publicado: (2011) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
por: Jamsen, Kris M, et al.
Publicado: (2012) -
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator
por: Flegg, Jennifer A, et al.
Publicado: (2011) -
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
por: Zaloumis, Sophie, et al.
Publicado: (2012)